AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00314-07v1
51/8/2911    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marchand, B.
Right arrow Articles by Götte, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marchand, B.
Right arrow Articles by Götte, M.
Antimicrobial Agents and Chemotherapy, August 2007, p. 2911-2919, Vol. 51, No. 8
0066-4804/07/$08.00+0     doi:10.1128/AAC.00314-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Effects of the Translocation Status of Human Immunodeficiency Virus Type 1 Reverse Transcriptase on the Efficiency of Excision of Tenofovir{triangledown}

Bruno Marchand,1 Kirsten L. White,2 John K. Ly,2 Nicolas A. Margot,2 Ruth Wang,2 Martin McDermott,2 Michael D. Miller,2 and Matthias Götte1,3,4*

Departments of Microbiology & Immunology,1 Medicine,3 Biochemistry, McGill University, Montréal, Québec, Canada,4 Gilead Sciences, Inc., Foster City, California 944042

Received 6 March 2007/ Returned for modification 23 April 2007/ Accepted 8 May 2007

The ATP-dependent phosphorolytic excision of nucleoside analogue reverse transcriptase inhibitors can diminish their inhibitory effects on human immunodeficiency virus replication. Previous studies have shown that excision can occur only when the reverse transcriptase complex exists in its pretranslocational state. Binding of the next complementary nucleotide causes the formation of a stable dead-end complex in the posttranslocational state, which blocks the excision reaction. To provide mechanistic insight into the excision of the acyclic phosphonate nucleotide analog tenofovir, we compared the efficiencies of the reaction in response to changes in the translocation status of the enzyme. We found that rates of excision of tenofovir with wild-type reverse transcriptase can be as high as those seen with 3'-azido-3'-deoxythymidine monophosphate (AZT-MP). Thymidine-associated mutations, which confer >100-fold and 3-fold decreased susceptibility to AZT and tenofovir, respectively, caused substantial increases in the efficiency of excision of both inhibitors. However, in contrast to the case for AZT-MP, the removal of tenofovir was highly sensitive to dead-end complex formation. Site-specific footprinting experiments revealed that complexes with AZT-terminated primers exist predominantly pretranslocation. In contrast, complexes with tenofovir-terminated primers are seen in both configurations. Low concentrations of the next nucleotide are sufficient to trap the complex posttranslocation despite the flexible, acyclic character of the compound. Thus, the relatively high rate of excision of tenofovir is partially neutralized by the facile switch to the posttranslocational state and by dead-end complex formation, which provides a degree of protection from excision in the cellular environment.


* Corresponding author. Mailing address: Department of Microbiology & Immunology, McGill University, Lyman Duff Medical Building, D-6, 3775 University St., Montreal, QC H3A 2B4, Canada. Phone: (514) 398-1365. Fax: (514) 398-7052. E-mail: matthias.gotte{at}mcgill.ca

{triangledown} Published ahead of print on 21 May 2007.


Antimicrobial Agents and Chemotherapy, August 2007, p. 2911-2919, Vol. 51, No. 8
0066-4804/07/$08.00+0     doi:10.1128/AAC.00314-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.